Webcast is Live on Monday, June 3, at 2:30 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--May. 21, 2013--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that Gary Maharaj, president and chief
executive officer, and Andy LaFrence, vice president of finance and
chief financial officer, will make a presentation to the investment
community at the Jefferies 2013 Global Healthcare Conference on Monday,
June 3, 2013, at 2:30 p.m. CT (3:30 p.m. ET) in New York City.
A live audio webcast of the presentation will be available on Monday,
June 3, by going to the investor relations portion of the Company’s
website at www.surmodics.com
and clicking on the webcast icon. In addition, the audio and slide
presentation will be archived on the Company’s website following the
meeting.
About SurModics, Inc.
SurModics’ mission is to exceed our
customers’ expectations and enhance patients’ well-being by providing
the world’s foremost, innovative surface modification technologies and in
vitro diagnostic chemical components. SurModics partners with the
world’s leading and emerging medical device, diagnostic and life science
companies to develop and commercialize innovative products designed to
improve patient diagnosis and treatment. Core offerings include surface
modification coating technologies that impart lubricity, prohealing, and
biocompatibility capabilities; and components for in vitro
diagnostic test kits and microarrays. SurModics is headquartered in Eden
Prairie, Minnesota. For more information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Source: SurModics, Inc.
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com
